Apple is the IBD Stock Of The Day as the consumer electronics giant prepares for a busy holiday shopping season.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Researchers reported no overall risk for IBD flare in ...

VIENNA — Researchers have determined a bidirectional relationship between inflammatory bowel disease (IBD) and type 1 diabetes (T1D), using both a cohort and case-control approach to analysis. Their ...

A Teva Pharmaceuticals drug being developed in partnership with Sanofi to hit a promising but competitive target for inflammation now has positive data from a clinical test in the two most common ...

The use of glucagon-like peptide 1 (GLP-1) receptor agonists is associated with a reduced risk for poor inflammatory bowel disease (IBD)–related outcomes in patients with both IBD and type 2 diabetes ...